Skip to content
10-K

Annual Report

REVELATION BIOSCIENCES, INC. REVB REVBW

0001193125-26-076552

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 3.72M sh
Shares Diluted FY 2025 · Dec 31, 2025 620.79K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 14.29K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$8.27M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$18.32M
Cash And Equivalents FY 2025 · Dec 31, 2025 $10.7M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.5M
Stockholders Equity FY 2025 · Dec 31, 2025 $8.86M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.71M
Current Liabilities FY 2025 · Dec 31, 2025 $2M
Current Liabilities FY 2025 · Dec 31, 2024 $1.91M
Total Liabilities FY 2025 · Dec 31, 2025 $2.72M
Total Liabilities FY 2025 · Dec 31, 2024 $1.91M
Current Assets FY 2025 · Dec 31, 2025 $10.81M
Current Assets FY 2025 · Dec 31, 2024 $6.57M
Total Assets FY 2025 · Dec 31, 2025 $11.58M
Total Assets FY 2025 · Dec 31, 2024 $6.62M
Eps Diluted FY 2025 · Dec 31, 2025 −$23.95
Eps Diluted restated FY 2025 · Dec 31, 2024 −$1,052.16
Eps Basic FY 2025 · Dec 31, 2025 −$23.95
Eps Basic restated FY 2025 · Dec 31, 2024 −$1,052.16
Sga Expense FY 2025 · Dec 31, 2025 $5.01M
Sga Expense FY 2025 · Dec 31, 2024 $4.43M
Rd Expense FY 2025 · Dec 31, 2025 $4.06M
Rd Expense FY 2025 · Dec 31, 2024 $3.55M
Net Income FY 2025 · Dec 31, 2025 −$8.91M
Net Income FY 2025 · Dec 31, 2024 −$15.04M
Operating Income FY 2025 · Dec 31, 2025 −$9.07M
Operating Income FY 2025 · Dec 31, 2024 −$7.98M
Capex FY 2025 · Dec 31, 2024 $19.17K